Laurus Labs Ltd Share Price

Overview

Laurus Labs Ltd share price is currently ₹1,789.08, up by ₹15.66 (0.88%) from its previous closing price of ₹1,773.42. The share price has gained 13.68% over the past month and gained 111.48% over the past year. The stock's 52-week low and high are ₹807.66 and ₹1,854.22, respectively. Laurus Labs Ltd has a market capitalisation of ₹ 97,360.00 Cr. The share price was last updated on 24 Aug 2026, 03:50 PM IST.

Laurus Labs Ltd
Laurus Labs Ltd
LAURUSLABS
 0.00
 15.66
0.88%
Healthcare
 0.00(%)1D

Updated: 24 Aug 2026, 03:50:57 pm IST

Market Data

Open Price

 1,791.67

Prev. Close

 1,773.42
 1,785.25

Day Low

 1,795.21

Day High

 807.66

52 Week Low

 1,854.22

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

88.35

Sector PE

42.03

PB Ratio

18.31

Sector PB

5.82

EPS

20.25

Dividend Yield

0.20

Today's Volume

2.859 M

5 Day Avg. Volume

1.655 M

PEG Ratio

0.60

Market Cap.

₹ 97,360.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsInterim Dividend of 60% at ₹1.2/Share
08-May-202608-May-2026
DividendsInterim Dividend of 40% at ₹0.8/Share
31-Oct-202531-Oct-2025
DividendsInterim Dividend of 40% at ₹0.8/Share
09-May-202509-May-2025
DividendsInterim Dividend of 20% at ₹0.4/Share
06-Nov-202406-Nov-2024

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
Mirae Asset Large & Midcap Fund - Regular Plan - Growth92.74 Lac
92.74 Lac
no change
Mirae Asset ELSS Tax Saver Fund - Regular Plan - Growth67.94 Lac
66.19 Lac
(2.58%)
Mirae Asset Midcap Fund - Regular Plan - Growth47.28 Lac
45.97 Lac
(2.76%)
UTI Nifty200 Momentum 30 Index Fund - Regular Plan - Growth26.92 Lac
26.87 Lac
(0.18%)
Axis Small Cap Fund - Regular Plan - Growth16.17 Lac
16.17 Lac
no change

About Laurus Labs Ltd 👋

Laurus Labs Limited is an India-based company. The Company is a pharmaceutical manufacturing organization. It is engaged in developing and manufacturing active pharmaceutical ingredients (APIs) and intermediates. It supplies anti-retroviral APIs and intermediates. It provides contract and custom manufacturing solutions, allowing client organizations to outsource various stages of the manufacturing process. It is also engaged in development and manufacturing of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements catering to the needs of stem cells and regenerative medicine, vaccines and biological drugs, cultured meat, and cell-culture media manufacturing. It offers precision fermentation as a contract development and manufacturing organization (CDMO) service. Its service is offered to protein companies and bio-manufacturers operating across healthcare, food, nutrition, personal care, and bio-based materials markets.

Frequently Asked Questions

What is the share price of Laurus Labs Ltd?

What is the market cap of Laurus Labs Ltd?

Should I buy Laurus Labs Ltd stock now?

What is the 52 week high and low of Laurus Labs Ltd?

Is the Laurus Labs Ltd stock good to buy?

Is Laurus Labs Ltd a good buy for the long term?

Is Laurus Labs Ltd overvalued or undervalued?

What is the PE and PB ratio of Laurus Labs Ltd?

Start Now